menu search

Snbl to acquire satsuma pharmaceuticals

Transaction delivers immediate value and liquidity to satsuma stockholders SNBL to acquire all outstand...

April 16, 2023, 11:41 pm

satsuma pharmaceuticals provides sts101 development program and corporate update

Further analysis of results from recently-completed SUMMIT Phase 3 efficacy trial of STS101 for the acute treatment of migraine shows differentiating ...

December 20, 2022, 2:21 pm


Search within

Pages Search Results: